Skip to main content

Table 2 Wilcoxon sign-rank test was used to test the difference between pre-PP1M and Post-PP1M

From: A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China

  Medicine costs Hospitalization costs Direct costs
pre-PP1M (¥) 8302 ± 4156 9155 ± 18816 17457 ± 17414
Post-PP1M (¥) 20121 ± 4580 2915 ± 8466 23030 ± 8648
Difference 142% -68.15% 31.92%
P < 0.01 0.074 < 0.01